sur Theranexus (EPA:ALTHX)
Theranexus: Monthly update of voting rights and shares
On January 16, 2025, Theranexus, a biopharmaceutical company specializing in rare neurological diseases, announced its share capital figures. As of December 31, 2024, the company had registered a total of 8,110,140 shares constituting its capital. Regarding theoretical voting rights, these amount to 9,182,541, in accordance with AMF regulations.
These figures include all shares attached to voting rights, including those that do not currently have them. This transparency is in line with current commercial obligations and stock market regulations. Theranexus, a company listed on Euronext Growth Paris, is continuing its efforts in therapeutic innovation.
R. P.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de Theranexus